‘World Cup of Fraud’

5/28/2015 In what looks to be the most widespread and lucrative corruption scandal in the global history of sport, the U.S. Justice Department has unsealed a 47-count indictment against 14 executives of the worldwide soccer governing body, FIFA. The executives are being charged with racketeering, wire fraud, and money laundering. The Justice Department alleges that


Supreme Court Rules War is not Excuse for missed Whistleblower Deadlines

5/27/2015 In a decision that helps to define the statute of limitations for whistleblower cases, the Supreme Court unanimously ruled Tuesday, May 26th that whistleblowers do not get extra time to file false claims complaints during a time of war. The case revolves around former Iraq contractor, Benjamin Carter, whose 2011 complaint under review alleges


Appeals Rulings Signal Punishment is Easing for Big Tobacco

  5/26/2015 Perhaps no industry besides investment banks has been hit as hard by the federal court system than tobacco over the past several years. A pair of recent appeals rulings, however, indicates a substantial turn in the industry’s decades-long financial flogging. On Friday, the D.C. Court of Appeals delivered a mixed-ruling, in which some


More Cable Consolidation as Charter buys Time Warner

5/26/2015 Charter Communications is expected to announce on Tuesday that the company has reached an agreement to purchase Time Warner Cable. If the deal passes regulatory scrutiny, the third and second largest cable providers, respectively, will provide heavy competition to industry leader Comcast, as well as other companies like DirecTV and Netflix. The estimated $55


Banks: Target, Mastercard Data Breach Settlement is Insufficient

5/25/2015 A lawsuit will continue in U.S. District Court in Minnesota regarding Target’s widespread 2013 pre-holiday data breach as banks rejected a $19 million settlement proposed last month. Over 40 million debit and credit cards were compromised during the breach, putting millions of cardholders’ information at risk. The settlement set aside by Target would have



Zerbaxa Labels Cause Confusion Over Dosages

5/21/2015 The FDA announced yesterday that it is warning healthcare professionals of potential problems with Zerbaxa (ceftolozane and tazobactam). Apparently, the Zerbaxa labels cause confusion over dosages. The risk stems from the vial label being approved with each individual active ingredients’ strength listed (e.g. 1 g/0.5 g). The product is not dosed like that, though,


FDA Posted an Alert Regarding Hospira’s LifeCare PCA3 and PCA5 Infusion Pumps

5/21/2015 Earlier this month, the FDA posted an alert regarding Hospira’s LifeCare PCA3 and PCA5 infusion pumps. The computerized systems are used to continuously deliver anesthetic or therapeutic drugs and can be programmed remotely over a hospital’s Ethernet or wireless service. Both Hospira and the FDA learned of certain security vulnerabilities in Hospira’s PCA3 and


SGLT2 Drugs Have Negative History with FDA

  5/21/2015 Quite surprising to me, I found that SGLT2 drugs have negative history with FDA. Not surprising, especially after finding the history, is the warning FDA released earlier this week. It appears that canagliflozin, sold as Invokana, may have created problems in the clinical trials that should have prevented its release. Just as other


TPP: The China Question

5/21/2015 As the Trans-Pacific Partnership (TPP) “fast track” debate continues its push through the congressional gauntlet, my fellow colleague Jay and I have analyzed hundreds of texts and perspectives surrounding the trade deal. We have covered labor, patent and trademarks, mass-torts, environmental concerns, and the highly controversial Investor State Dispute Resolution (ISDS) system, and little